BAT to Launch VELO Plus in US with 7 Flavors, Using Synthetic Nicotine

BAT by 2FIRSTS.ai

Dec.23.2024

BAT to Launch VELO Plus in US with 7 Flavors, Using Synthetic Nicotine

British American Tobacco (BAT) plans to launch VELO Plus in the US by the end of 2024.

According to Tobacco Insider, on December 22, British American Tobacco (BAT) announced during a capital markets day event on October 16, their plans to launch VELO Plus in the United States by the end of 2024. Subsequently, Modoral Brands Inc., the operating company of Reynolds Tobacco (Reynolds American Inc.), officially launched the VELO Plus series in the United States in December 2024.

BAT stated that VELO Plus features an improved nicotine pouch design with a hinged disposal lid for easy storage and disposal of used nicotine pouches.

VELO Plus manufacturer recommends a retail price of $5.59 for a 20-pack can. At regular discount price, VELO Plus is priced at $3.99 per can, and the bulk discount price is $3.35 per can. Unlike VELO Original, VELO Plus uses synthetic nicotine instead of tobacco extracted nicotine.

VELO Plus offers two levels of nicotine concentration (6mg and 9mg) and seven different flavors: mint menthol, peppermint, wintergreen, mint, citrus cool, wild berry, and dragon fruit. The dragon fruit flavor is exclusively sold at 7-Eleven convenience stores.

British American Tobacco plans to introduce a "Smooth Tobacco" flavor option in the first quarter of 2025. However, VELO Plus initially has fewer flavor options than VELO Original, so it is expected that BAT will expand the range of flavors for VELO Plus in the coming months.

References:

[1] VELO Plus: USA

Also Read:

[1] BAT Ireland Reports 22% Revenue from Vapes, 3% from VELO in 2023

[2] Rampant Counterfeit ZYN Nicotine Pouches in U.S. Market

[3] BAT to Launch Synthetic Nicotine Pouch Velo Plus in the U.S., Expected in 2025

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement

President Donald Trump signed the Continuing Appropriations Act, 2026 (H.R.5371) on November 12, Section 772 of Part B—the Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act (S.2256)—requires the FDA to allocate no less than $200 million in tobacco user fees to enforce regulations against illegal e-cigarettes, vapes, and other ENDS products. At least $2 million of this funding supports a federal multi-agency task force targeting products originating from the China.

Nov.14 by 2FIRSTS.ai

Vietnam Drafts Administrative Penalties for E-Cigarette Use, Setting Fines up to USD 380

Vietnam plans to formalise penalties for e-cigarette and heated tobacco use under a draft decree. Individual users could be fined VND 3–5 million (USD 114–190), while premises allowing use face fines up to VND 10 million (USD 380). Higher penalties apply to business violations.

Dec.25 by 2FIRSTS.ai

AG Miyares Argues Vape Ban Consistent with Federal Law, Seeks Dismissal

Virginia Attorney General Jason Miyares and Tax Commissioner James J. Alex have asked a federal court to dismiss a lawsuit challenging the state’s ban on flavored e-cigarettes. They argue plaintiffs lack standing because the products are already illegal under federal law. The state denies claims of federal preemption and asserts sovereign immunity, maintaining that its ban aligns with its authority to protect public health.

Nov.24 by 2FIRSTS.ai

Lawmakers Clash as Mexico Moves to Criminalize Sale and Promotion of Vapes

Mexico’s Chamber of Deputies Health Commission has approved a bill establishing a total ban on vapes and e-cigarettes, with penalties ranging from one to eight years in prison and fines between Mex$11,000 and Mex$226,000 (USD ≈$600–$12,300). The proposal sparked controversy among opposition lawmakers, who argued that the legislation criminalizes users rather than focusing on regulation and prevention.